Tracking heart and blood vessel events after major non-heart surgery
This study follows people after major surgery to see what predicts heart and blood vessel problems later. It does not test a new drug; it mainly collects health information to help clinicians reduce risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 45 or older
- You are having major surgery that is expected to last at least 2 hours and require at least 2 days after surgery
- You have either known heart/blood vessel disease (like coronary artery disease, stroke, heart failure, or poor blood flow to the legs) or at least two major risk factors (like high blood pressure, diabetes, kidney disease, smoking in the past 2+ years, high cholesterol, prior TIA, age 65+, or very high-risk surgery)
- You did not have a serious “acute” heart/blood vessel event within the last 30 days before surgery
- Your overall health rating with anesthesia is not “5 or higher” (see trial staff for what that means)
- You have not joined this study before and can understand and sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether personalized blood pressure management during and after major surgery can reduce complications and death in older adults with heart or blood vessel risks. It aims to find the safest blood pressure targets for each patient.
This study checks blood and other lab “biomarkers” during the time before and after major surgeries to see if they can help guide perioperative care. You might be eligible if you are having certain planned heart, lung, GI, or blood-vessel surgeries and can give informed consent.
This study checks whether close monitoring of vital signs around the time of non-cardiac surgery can help identify small heart injuries (called perioperative myocardial infarction or injury). It may help doctors spot people at higher risk sooner, especially after certain major surgeries.
This study looks at certain health markers (called biomarkers) in your blood before surgery. The goal is to see if these markers can help predict how well you recover after non-cardiac surgery, which might improve care for future patients.
This study looks at whether a simple heart rate and blood pressure measure can help predict if patients with heart conditions will have heart problems after major abdominal surgery. It may help doctors monitor patients more closely and prevent complications.
This study checks for hidden heart damage after major abdominal surgery by measuring a blood marker called troponin. It uses this information to predict and improve outcomes in the 30 days after surgery.
Hear when a new Noncardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.